A phase 1 study of repeat radiation, minocycline, and bevacizumab in patients with recurrent glioma (RAMBO).
Adam Louis Cohen
No relevant relationships to disclose
Christopher James Anker
No relevant relationships to disclose
Karen Salzman
No relevant relationships to disclose
Randy L. Jensen
No relevant relationships to disclose
Dennis C. Shrieve
No relevant relationships to disclose
Howard Colman
Consultant or Advisory Role - Genentech; Roche; Sigma-Tau
Stock Ownership - Castle Biosciences
Honoraria - Merck